Surmodics announces first patient use of radial access microcatheter

Surmodics announced that Dr. Ankur Lodha, Lafayette, La., and Dr. Pradeep Nair, Houma, La., are the first physicians to use the company’s Sublime adial access microcatheter. Drs. Lodha and Nair are interventional cardiologists at the Cardiovascular Institute of the South. The Sublime microcatheter is in limited market evaluation. The full suite of Sublime microcatheters will be launched in FY 2024. The Sublime portfolio will include the industry’s first suite of 0.014", 0.018", and 0.035" high-performance peripheral microcatheters. "For peripheral as well as coronary interventions, radial access is safer than femoral access and much preferred by patients," said Dr. Lodha. "I’m pleased to report that the Sublime microcatheter performed exceptionally well during our first uses of the device in treating peripheral arterial disease." "The lack of long-length, high-performance catheters for peripheral procedures has slowed adoption of radial access for treatment of lower extremity artery disease," added Dr. Nair. "Sublime microcatheters will fill a major gap in the peripheral-intervention toolkit, including for procedures from access sites other than the wrist." The Sublime microcatheter is in limited market evaluation. The full suite of Sublime microcatheters will be launched in FY 2024. The Sublime portfolio will include the industry’s first suite of 0.014", 0.018", and 0.035" high-performance peripheral microcatheters. "For peripheral as well as coronary interventions, radial access is safer than femoral access and much preferred by patients," said Dr. Lodha. "I’m pleased to report that the Sublime microcatheter performed exceptionally well during our first uses of the device in treating peripheral arterial disease."